Postpartum Thyroiditis: Treating Two Phases of the Same Disease Differently
A new mother's thyroid has swung from mildly overactive to now genuinely underactive four months after delivery. The disagreement isn't about the hyperthyroid phase, which everyone already handled the same way — it's about how low, and how symptomatic, she needs to be before the hypothyroid phase earns treatment.
Naomi S., a 30-year-old nurse, delivered her first child four months ago and returns today reporting fatigue and low mood she'd initially chalked up to new motherhood, along with new constipation and hair that seems to be shedding more than usual. Eight weeks postpartum, she had a brief episode of palpitations and mild heat intolerance that was managed at the time with a short course of propranolol alone, no antithyroid drug, after labs showed a suppressed TSH with a thyroid uptake scan consistent with destructive thyroiditis rather than new Graves' disease — a distinction that mattered because the treatment approaches for those two causes of postpartum hyperthyroidism are entirely different. That hyperthyroid phase resolved on its own within a few weeks, as expected. Today her TSH has swung the other direction: 8.9 μIU/mL, with a free T4 at the low end of normal, and a TPO antibody she now knows, from a test sent at her first postpartum visit, was already positive.
Postpartum thyroiditis follows a well-described pattern — a destructive release of stored hormone causing transient hyperthyroidism, followed weeks to months later by a hypothyroid phase as the gland recovers its own synthetic capacity too slowly to keep up, most often resolving spontaneously within a year. Her positive TPO antibody is the single strongest predictor in this picture, not a side detail — Stagnaro-Green's review of postpartum thyroiditis makes antibody status the central prognostic variable: TPO-positive women with postpartum thyroiditis carry meaningfully higher odds both of a more pronounced hypothyroid phase and of the process not fully resolving, progressing instead to permanent hypothyroidism over the following years. Her current TSH, at 8.9, is genuinely elevated but not dramatically so, and her symptoms — fatigue, low mood, hair shedding — overlap heavily with ordinary postpartum experience in a woman with a new infant, whether or not her thyroid were involved at all.
Deciding whether the hypothyroid phase has crossed into treatment territory
I'd start levothyroxine now rather than wait this out. Her TPO positivity is a real predictor, and Stagnaro-Green's series put real numbers behind it: this phase is more likely to be pronounced and less likely to spontaneously resolve on its own timeline than a TPO-negative patient's would be, and she's already symptomatic. Treating her doesn't foreclose the possibility this remits — we can trial off it later.
I'd hold off. Her TSH is elevated but not dramatically — well short of the range that typically prompts starting treatment outside pregnancy or postpartum thyroiditis specifically — and her symptoms are genuinely hard to separate from ordinary new-motherhood exhaustion.
You're treating her TPO positivity as though it settles the decision on its own, but that marker predicts a population-level likelihood of a more severe or persistent course, not a certainty for her individually — and a four-month-old baby is more than enough to explain fatigue and low mood without needing her thyroid to be the whole story.
I'd start a modest levothyroxine dose now, not because either of you is wrong about the uncertainty, but because the actual cost of a brief, low-dose trial is small and the marker really does shift the odds enough to act on. Recheck in six to eight weeks, and if she's asymptomatic and her TSH would stay normal off the medication — testable later with a supervised taper — we stop rather than committing her to indefinite therapy on the strength of one elevated value and one positive antibody.
Agreed: start low-dose levothyroxine now, recheck in six to eight weeks, with an explicit plan to attempt a supervised taper later rather than assuming the treatment will be permanent.
Not agreed: how soon the taper attempt should happen if she's doing well. The endocrinologist would wait a full year, past the typical natural-resolution window for postpartum thyroiditis, before testing whether she still needs it; the primary care physician would attempt a taper as early as three months in, worried that an early, effective-feeling treatment could otherwise quietly become years of unnecessary medication.